SNSE Sensei Biotherapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SNSE

Price (delayed)

$1.79

Market cap

$44.88M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.22

Enterprise value

$38.07M

Sensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company has developed ...

Highlights
The net income has increased by 30% year-on-year and by 12% since the previous quarter
SNSE's debt is down by 23% YoY and by 8% from the previous quarter
SNSE's equity is down by 37% YoY and by 9% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.senseibio.com
Peers: OMER OMGA

Key stats

What are the main financial stats of SNSE
Market
Shares outstanding
25.07M
Market cap
$44.88M
Enterprise value
$38.07M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.69
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$33.96M
EBITDA
-$31.25M
Free cash flow
-$32.04M
Per share
EPS
-$1.22
Free cash flow per share
-$1.15
Book value per share
$2.6
Revenue per share
$0
TBVPS
$2.66
Balance sheet
Total assets
$74.37M
Total liabilities
$9.48M
Debt
$6.21M
Equity
$64.9M
Working capital
$61.61M
Liquidity
Debt to equity
0.1
Current ratio
11.92
Quick ratio
11.65
Net debt/EBITDA
0.22
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-38.6%
Return on equity
-44%
Return on invested capital
-43.3%
Return on capital employed
-49.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SNSE stock price

How has the Sensei Biotherapeutics stock price performed over time
Intraday
8.48%
1 week
73.79%
1 month
80.81%
1 year
19.33%
YTD
158.67%
QTD
70.48%

Financial performance

How have Sensei Biotherapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$37.06M
Net income
-$34.1M
Gross margin
N/A
Net margin
N/A
The net income has increased by 30% year-on-year and by 12% since the previous quarter
The operating income has grown by 26% YoY and by 12% from the previous quarter

Growth

What is Sensei Biotherapeutics's growth rate over time

Valuation

What is Sensei Biotherapeutics stock price valuation
P/E
N/A
P/B
0.69
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
SNSE's EPS is up by 23% year-on-year and by 8% since the previous quarter
The price to book (P/B) is 73% higher than the last 4 quarters average of 0.4
SNSE's equity is down by 37% YoY and by 9% from the previous quarter

Efficiency

How efficient is Sensei Biotherapeutics business performance
The ROIC fell by 10% YoY but it rose by 2.5% QoQ
SNSE's ROE is down by 8% YoY
The company's return on assets fell by 6% YoY

Dividends

What is SNSE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SNSE.

Financial health

How did Sensei Biotherapeutics financials performed over time
Sensei Biotherapeutics's total liabilities has decreased by 37% YoY and by 11% from the previous quarter
Sensei Biotherapeutics's total assets has decreased by 37% YoY and by 9% from the previous quarter
SNSE's debt is 90% less than its equity
SNSE's equity is down by 37% YoY and by 9% from the previous quarter
SNSE's debt to equity is up by 25% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.